Dongjun Dai
Overview
Explore the profile of Dongjun Dai including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
58
Citations
1061
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Chen H, Shui Y, Tan Y, Dai D, Chen L, Jiang K, et al.
J Cancer Educ
. 2024 Apr;
39(5):537-545.
PMID: 38622328
Residents are actively involved in patient assessment and all aspects of patient care, and they are critical in providing nutritional support education and treatment for patients with cancer. This study...
2.
Tian Q, Jiang L, Dai D, Liu L, Shi X, Guo Y, et al.
J Clin Oncol
. 2024 Apr;
42(15):1754-1765.
PMID: 38560819
Purpose: To identify subgroups of patients with early-stage (pT1-2N0M0) oral tongue squamous cell carcinoma (OTSCC) who may benefit from postoperative radiotherapy (PORT). Patients And Methods: This retrospective cohort study included...
3.
Dai D, Wu D, Ni R, Li P, Tian Z, Shui Y, et al.
Front Mol Biosci
. 2023 Jul;
10:1162409.
PMID: 37503539
The goal of our bioinformatics study was to comprehensively analyze the association between the whole calpain family members and the progression and prognosis of hepatocellular carcinoma (HCC). The data were...
4.
Dai D, Liu L, Guo Y, Shui Y, Wei Q
Cancers (Basel)
. 2023 Jan;
15(1).
PMID: 36612054
The aim of our study was to perform a comprehensive analysis of the gene expression, copy number variation (CNV) and mutation of key mitophagy genes in the progression and prognosis...
5.
Zhang C, Dai D, Zhang W, Yang W, Guo Y, Wei Q
J Gastroenterol Hepatol
. 2022 Sep;
37(11):2039-2050.
PMID: 36066844
Hepatocellular carcinoma (HCC) is the most common liver malignancy that can be developed from hepatitis B and cirrhosis. Many pathophysiological alterations, including hepatitis B virus (HBV) DNA integration, oxidative stress,...
6.
Dai D, Tian Q, Yu G, Shui Y, Jiang H, Wei Q
Cancers (Basel)
. 2022 Jun;
14(12).
PMID: 35740689
The aim of the current study was to evaluate the influence of severe radiation-induced lymphopenia (RIL) on the outcomes of esophageal cancer (EC). A systematic review and meta-analysis was performed...
7.
Dai D, Tian Q, Shui Y, Li J, Wei Q
Radiother Oncol
. 2022 Mar;
170:243.
PMID: 35283269
No abstract available.
8.
Dai D, Tian Q, Shui Y, Li J, Wei Q
Radiother Oncol
. 2022 Jan;
168:28-36.
PMID: 35017020
Objectives: Radiotherapy is a key part of head and neck cancer (HNC) treatment. Radiation induced lymphopenia (RIL) is a severe complication of radiotherapy. The aim of this study was to...
9.
Dai D, Guo Y, Shui Y, Li J, Jiang B, Wei Q
Front Mol Biosci
. 2021 Dec;
8:775562.
PMID: 34970597
The aim of our study was to investigate the potential predictive value of the combination of radiosensitivity gene signature and PD-L1 expression for the prognosis of locally advanced head and...
10.
Dai D, Shen Y, Lu J, Wang Y, Zhu W, Bao Y, et al.
J Diabetes Complications
. 2021 Jun;
35(9):107971.
PMID: 34187717
Aim: There is a paucity of studies regarding the association between long-term glycemic variability with the risk of diabetic retinopathy (DR) in patients with type 2 diabetes. Therefore, the purpose...